Evaluation of the Clinical and Radiological Outcome of Uncemented Femoral Stems According to Their Proximal Coating (ETNA)

Evaluation of the Clinical and Radiological Outcome of Uncemented Femoral Stems According to Their Proximal Coating.

Evaluation of the clinical and radiological outcome of uncemented femoral stems according to their proximal coating.

Retrospective study

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

On a large population of patients having undergone total hip arthroplasty, divided into two cohorts constituted according to the type of femoral stem implanted (with or without proximal coating by MectaGrip):

Primary objective: To compare between the two groups the radiological osseointegration of the stems five years after arthroplasty.

Secondary objectives: To compare between the groups

  • The functional outcome of the arthroplasty
  • The frequency of radiological abnormalities (stress shielding, osteolysis, periprosthetic fractures or cracks, periprosthetic ossifications)
  • Frequency of complications

Study Type

Observational

Enrollment (Actual)

408

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Paris, France, 75005
        • Clinique du Sport

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Patients who have had a total hip replacement for at least five years.

Description

Inclusion Criteria:

  • Patient aged 18 years or older, having been informed of the research
  • A patient with at least five years of uncemented total hip replacement implanted as a first-line procedure
  • A patient who has been regularly monitored since surgery and for whom all clinical and radiological data are available at the five-year follow-up visit

Exclusion Criteria:

  • Patient operated for revision
  • History of femoral fracture (pre or per operative)
  • Chronic treatment likely to affect calcium metabolism and ossification
  • Patient under legal protection, guardianship or curatorship
  • A patient who has indicated his or her opposition to the use of his or her medical data (by completing and returning the non-opposition form that will be sent to him or her).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Engh and Massin Score
Time Frame: 5 years
The osseointegration of each stem will be assessed by the Engh and Massin score which evaluates the fixation (bone margins and bridges) and the stability of the stem (margins, pedestal, remodelling of the calcar, deterioration of the prosthesis-bone interface, migration, and particles) by associating negative or positive values for each of the parameters. The total constitutes an anatomopathological diagnosis of "confirmed bone rehab" (+ 10 pts and more), suspected (between 0 and + 10 pts), "fibrous encapsulation" (between - 10 and 0 pts) or an "unstable" prosthesis (below - 10 pts).
5 years

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Stability of the femoral stem: axial migration (sinking)
Time Frame: 5 years
Radiological assessment of the stability of the femoral stem: axial migration (sinking)
5 years
Stability of the femoral stem: frontal migration (varisation)
Time Frame: 5 years
Radiological assessment of the stability of the femoral stem: frontal migration (varisation)
5 years
Gruen's zones assessment
Time Frame: 5 years
Images of edging, osteolysis, stress shielding according to Gruen's zones
5 years
Periprosthetic ossifications (Brooker classification)
Time Frame: 5 years
Periprosthetic ossifications (Brooker classification)
5 years
Periprosthetic fractures (Vancouver classification)
Time Frame: 5 years
Periprosthetic fractures (Vancouver classification)
5 years
Harris Hip Score (HHS)
Time Frame: 5 years
The Harris Hip Score (HHS) consists of a history part and a clinical examination part that takes into account pain, function and mobility of the hip. A score between 90 and 100 points is defined as excellent, between 80 and 90 as good, between 70 and 80 as fair and below 70 as poor.
5 years
Oxford hip score
Time Frame: 5 years
The Oxford score is a self-assessment of hip joint function consisting of 12 questions scored from 0 to 4. The total score is calculated by adding up the results of each question. The lower the score, the more severe the functional impact.
5 years
Forgotten Joint Score
Time Frame: 5 years
Le Forgotten Joint Score (FJS-12), est un auto-questionnaire compose de 12 questions évaluant le degré d'oubli des prothèses de hanche dans une situation donnée de la vie quotidienne. Chaque réponse est choisie dans une échelle de Likert à 5 points avec les options de réponse allant de jamais (0) la plupart du temps (4).
5 years
Life span of prostheses
Time Frame: 5 years
The life span is the time between the implantation of the prosthesis and its complete or partial surgical revision.
5 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Frédéric LAUDE, MD PD, Clinique du Sport

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 30, 2021

Primary Completion (Actual)

December 26, 2021

Study Completion (Actual)

December 26, 2021

Study Registration Dates

First Submitted

August 16, 2021

First Submitted That Met QC Criteria

August 17, 2021

First Posted (Actual)

August 20, 2021

Study Record Updates

Last Update Posted (Actual)

July 1, 2024

Last Update Submitted That Met QC Criteria

June 28, 2024

Last Verified

June 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • COS-RGDS-2019-12-012

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Arthroplasty

Clinical Trials on Cohort observation

Subscribe